Biao Xu
- Geriatrics and Gerontology top 10%
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research 4
-
- Cardiovascular Function and Risk Factors 3
-
- Adipose Tissue and Metabolism 2
-
- Cardiac Structural Anomalies and Repair 2
-
- RNA modifications and cancer 2
- Angiogenesis and VEGF in Cancer 2
-
- Natural Antidiabetic Agents Studies 2
-
- Proteoglycans and glycosaminoglycans research 2
- Co-authors
- Jun XieHan WuGuannan LiRan LiJianzhou ChenQinhua ChenZhonghai WeiLina Kang
- Journals
- Biochemical and Biophysical Research Communications (1 paper)Cell Death and Differentiation (1 paper)Journal of Cellular Physiology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Biao Xu
17 papers receiving 440 citations
Peers
Comparison fields: 5 of 78
- Geriatrics and Gerontology 51
- Clinical Biochemistry 49
- Cardiology and Cardiovascular Medicine 106
- Physiology 16
- Nephrology 22
Countries citing papers authored by Biao Xu
This map shows the geographic impact of Biao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Biao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biao Xu more than expected).
Fields of papers citing papers by Biao Xu
This network shows the impact of papers produced by Biao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Biao Xu. The network helps show where Biao Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Biao Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 7 | |
| 2 | 2023 | 4 | |
| 3 | 2022 | 6 | |
| 4 | 2021 | 10 | |
| 5 | 2018 | 14 | |
| 6 | 2018 | 14 | |
| 7 | 2018 | 110 | |
| 8 | 2017 | 11 | |
| 9 | 2016 | 35 | |
| 10 | 2016 | 44 | |
| 11 | 2016 | 108 | |
| 12 | 2016 | 10 | |
| 13 | 2016 | 9 | |
| 14 | 2016 | 18 | |
| 15 | 2014 | 43 | |
| 16 | 2013 | 1 | |
| 17 | Effects of advanced glycation end products on activity and expression of eNOS in human umbilical vein endothelial cells | 2004 | 1 |
About Biao Xu
Biao Xu is a scholar working on Clinical Biochemistry, Cancer Research and Cardiology and Cardiovascular Medicine, having authored 17 papers that have together received 445 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (4 papers), Cardiovascular Function and Risk Factors (3 papers), Adipose Tissue and Metabolism (2 papers), Cardiac Structural Anomalies and Repair (2 papers), RNA modifications and cancer (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Natural Antidiabetic Agents Studies (2 papers) and Proteoglycans and glycosaminoglycans research (2 papers). The work is most often cited by research in Geriatrics and Gerontology (51 citations), Clinical Biochemistry (49 citations) and Cardiology and Cardiovascular Medicine (106 citations). Biao Xu has collaborated with scholars based in China and United States. Frequent co-authors include Jun Xie, Han Wu, Guannan Li, Ran Li, Jianzhou Chen, Qinhua Chen, Zhonghai Wei, Lina Kang, Wencheng Di and Yang Yang. Their work appears in journals such as Biochemical and Biophysical Research Communications, Cell Death and Differentiation and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.